Given that BRG1 is silenced in ~16% of primary lung cancers [7], the random sequencing of 70 lung cancers conducted by Medina et al. [58] would have been expected to identify 7-11 tumors with mutations (even if the tumors had been chosen at random). This evidence concerns the gene SMARCA4 and lung cancer.